What is the current Price Target for the bluebird bio, Inc. stock?

The average bluebird bio, Inc. target price is $8.00. This is 60.97% higher than the current stock price. 1 Analyst has issued a bluebird bio, Inc. price target 2026.

How high will the bluebird bio, Inc. stock rise?

No reliable answer can be given as to how high the bluebird bio, Inc. stock will rise. The performance of stocks, including the bluebird bio, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the bluebird bio, Inc. stock today?

The performance of bluebird bio, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the bluebird bio, Inc. stock fall?

The decline in bluebird bio, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

bluebird bio, Inc. Forecast, price target & analysts

$4.97

0.00%

Nasdaq, Thu, Jun 12 2025

ISIN

US09609G1004

Symbol

BLUE

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

bluebird bio, Inc. Target price 2025 - Analyst rating & recommendation

bluebird bio, Inc. Classifications & Recommendation:

Buy

100%

bluebird bio, Inc. Price Target

Target Price	$8.00
Price	$4.97
Potential	60.97% register free of charge
Number of Estimates	1

	1 Analyst has issued a bluebird bio, Inc. price target 2026. The average bluebird bio, Inc. target price is $8.00. This is 60.97% register free of charge higher than the current stock price.
	A rating was issued by 1 analysts: 1 Analysts recommend bluebird bio, Inc. to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the bluebird bio, Inc. stock has an average upside potential 2026 of 60.97% register free of charge . Most analysts recommend the bluebird bio, Inc. stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-24.84	-11.16
	35.63%	55.07%
P/E		negative

1 Analysts have issued a bluebird bio, Inc. forecast for earnings per share. The average bluebird bio, Inc. EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-24.84	35.63%
2025	$-11.16 55.07% Unlock
2026	$-8.56 23.30% Unlock
2027	$-6.86 19.86% Unlock

Current	-0.24	58.00%
2025	-0.45 85.64% Unlock
2026	-0.58 28.89% Unlock
2027	-0.72 24.14% Unlock

bluebird bio, Inc....

Current bluebird bio, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Barclays	Locked ➜ Locked	Locked	Mar 31 2025
JP Morgan	Locked ➜ Locked	Locked	Feb 24 2025
Wells Fargo	Locked ➜ Locked	Locked	Feb 24 2025
Barclays	Locked ➜ Locked	Locked	Dec 31 2024
B of A Securities	Locked ➜ Locked	Locked	Nov 15 2024
Barclays	Locked ➜ Locked	Locked	Nov 15 2024
RBC Capital	Locked ➜ Locked	Locked	Nov 15 2024

Analyst Rating	Date
Locked Barclays: Locked ➜ Locked	Mar 31 2025
Locked JP Morgan: Locked ➜ Locked	Feb 24 2025
Locked Wells Fargo: Locked ➜ Locked	Feb 24 2025
Locked Barclays: Locked ➜ Locked	Dec 31 2024
Locked B of A Securities: Locked ➜ Locked	Nov 15 2024
Locked Barclays: Locked ➜ Locked	Nov 15 2024
Locked RBC Capital: Locked ➜ Locked	Nov 15 2024

Discover more stocks with a high price target

TUI 69.05%

Alibaba Group Holding Ltd 42.41%

NIO ADR 41.21%

MongoDB 32.46%

Adidas 31.10%

BioNTech SE - ADR 30.88%

Deutsche Telekom 26.47%

Novo Nordisk 25.31%

Tencent Holdings Ltd. 25.24%

BYD 22.43%

NVIDIA 20.92%

Porsche 18.08%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now